EA199600060A1 - Preparation protecting the liver suffering from hepatitis - Google Patents

Preparation protecting the liver suffering from hepatitis

Info

Publication number
EA199600060A1
EA199600060A1 EA199600060A EA199600060A EA199600060A1 EA 199600060 A1 EA199600060 A1 EA 199600060A1 EA 199600060 A EA199600060 A EA 199600060A EA 199600060 A EA199600060 A EA 199600060A EA 199600060 A1 EA199600060 A1 EA 199600060A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hepatitis
liver
mechanisms
suffering
preparation protecting
Prior art date
Application number
EA199600060A
Other languages
Russian (ru)
Other versions
EA000210B1 (en
Inventor
Людмила Федоровна Виноградова
Темирболат Темболатович Березов
Елена Валентиновна Харлицкая
Татьяна Семеновна Илларионова
Светлана Степановна Буробина
Нина Сергеевна Манякина
Original Assignee
Российский Университет Дружбы Народов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Российский Университет Дружбы Народов filed Critical Российский Университет Дружбы Народов
Priority to EA199600060A priority Critical patent/EA000210B1/en
Publication of EA199600060A1 publication Critical patent/EA199600060A1/en
Publication of EA000210B1 publication Critical patent/EA000210B1/en

Links

Abstract

Изобретение относится к фармакологии. Сущность изобретения заключается в том, что препарат, защищающий печень при гепатите, содержит витамин Е, убихинон-9 или -10 и селенит натрия при следующих массовых соотношениях ингредиентов в расчете на 1 кг массы тела:В результате применения предложенного препарата происходит торможение первоначальных пусковых молекулярных механизмов повреждения клеточных мембран, обеспечивающих нормальное функционирование клетки, а также процессы анаболизма и стимуляцию иммунных механизмов.The invention relates to pharmacology. The essence of the invention lies in the fact that the drug that protects the liver in hepatitis, contains vitamin E, ubiquinone-9 or -10 and sodium selenite at the following mass ratios of ingredients per 1 kg of body weight: mechanisms of damage to cell membranes, ensuring the normal functioning of the cell, as well as anabolic processes and stimulation of immune mechanisms.

EA199600060A 1996-04-08 1996-04-08 Compound protecting lever against virus hepatitis EA000210B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA199600060A EA000210B1 (en) 1996-04-08 1996-04-08 Compound protecting lever against virus hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA199600060A EA000210B1 (en) 1996-04-08 1996-04-08 Compound protecting lever against virus hepatitis

Publications (2)

Publication Number Publication Date
EA199600060A1 true EA199600060A1 (en) 1997-09-30
EA000210B1 EA000210B1 (en) 1998-12-24

Family

ID=8161390

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199600060A EA000210B1 (en) 1996-04-08 1996-04-08 Compound protecting lever against virus hepatitis

Country Status (1)

Country Link
EA (1) EA000210B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438481A1 (en) * 1978-10-11 1980-05-09 Bugard Pierre Antiinflammatory, antidepressant and eutrophic compsns. - contg. polar lipid, lipolytic enzyme, vitamin=E or synthetic antioxidant and selenium cpd.
DE3512054A1 (en) * 1985-04-02 1986-10-02 HERMES Fabrik pharmazeutischer Präparate Franz Gradinger Gmbh & Co, 8023 Großhesselohe PHARMACEUTICAL PREPARATION
DE3542309A1 (en) * 1985-11-29 1987-06-04 Cardona Federico Dr Medicinal antioxidant
SU1766412A1 (en) * 1990-11-13 1992-10-07 Ленинградский научно-исследовательский институт гигиены труда и профессиональных заболеваний Method for treating chronic intoxication with acrylates

Also Published As

Publication number Publication date
EA000210B1 (en) 1998-12-24

Similar Documents

Publication Publication Date Title
GEP19981289B (en) Method for Preparing Preserved Medicinal Means Containing Human Protein and Medicinal Means
EA199700135A1 (en) INHIBITORS OF CELLULAR ADHESION
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
EA200100872A1 (en) COMPOSITION VALDEKOKSIBA
IL140710A0 (en) Pulmonary delivery of active agents
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
MY115211A (en) Novel amino acid derivatives, their preparation and use
MY117323A (en) Method of scavenging free radicals using orange extract
EP0174279A3 (en) Improvements in relation to cyclosporin therapy
HK1048819A1 (en) Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
ID23424A (en) GLIKOKONJUGUS OF 20 (S) -CAMPTOTESIN
DK0948319T3 (en) Encapsulated antibody-forming cells
EA199600060A1 (en) Preparation protecting the liver suffering from hepatitis
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
ATE227565T1 (en) ORAL APPLICABLE GRANULES OF HEXAHYDROPYRAZINE DERIVATIVES
TR200002293T2 (en) Pharmaceutical compositions.
WO2001095785A3 (en) Modulation of immune response and methods based thereon
IE840977L (en) Pharmaceutical preparations
UA27142C2 (en) Pharmaceutical composition
BG104452A (en) New derivatives of the methylenebisphosphonic acid
BR9812002A (en) Compounds with anti-first pass effect
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
CA2255867A1 (en) Chitosan induced immunopotentiation

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU